| Indicators | Browse All

Eli Lilly and Company (LLY)

Healthcare | Drug Manufacturers - General | Indianapolis, United States | NYSE
1,181.87 USD -6.71 (-0.565%) ⇩ (July 13, 2026, 4:03 p.m. EDT)
After hours: 1,181.94 +0.07 (0.006%) ⇧ (July 13, 2026, 7:59 p.m. EDT)
Short-term:★★★★☆Long-term:★★★★★Dividends:★★☆☆☆
Hot Take ↕ | July 11, 2026, 4:47 a.m. EDT

The long-term investment case remains exceptionally strong, driven by a dominant competitive position and explosive revenue growth that has compounded nearly tenfold over the last nine years. While the stock faced a single year of price correction recently, the underlying business fundamentals—specifically a return on equity exceeding 100% and robust free cash flow—justify a top-tier buy-and-hold classification. The near-term outlook is bullish, with price momentum building significantly above key moving averages and options flow placing heavy bets on further appreciation toward the 1500 mark. Investors should ignore the low dividend yield, as this is a growth engine rather than an income vehicle, and view the current valuation as a premium for a business delivering superior returns on capital.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.199035
AutoARIMA0.203063
AutoETS0.203064
AutoTheta0.236059

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 44%
H-stat 5.89
Ljung-Box p 0.000
Jarque-Bera p 0.401
Excess Kurtosis -0.15
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-08-13
Last Dividend Date 2026-05-14
Debt to Equity Ratio 139.015
Revenue per Share 80.613
Market Cap 1,053,922,361,344
Trailing P/E 41.95
Forward P/E 26.27
Beta 0.51
Profit Margins 34.99%
Website https://www.lilly.com

As of July 11, 2026, 4:47 a.m. EDT: Speculators are positioning for continued upside with significant call open interest walls established at 1300 and 1500, suggesting a target range well above current levels. However, there is substantial put buying at deep strikes below 700, indicating institutional hedging against a potential sharp correction or earnings volatility. Implied volatility is elevated at deep strikes, reflecting uncertainty about the magnitude of moves rather than direction.

Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.17% 0.70% 0.71% 0.94%
Dividend History
Date Dividend Yield %
2026-05-15 1.730000 0.172153
2026-02-13 1.730000 0.166346
2025-11-14 1.500000 0.146301
2025-08-15 1.500000 0.213910
2025-05-16 1.500000 0.198049
2025-02-14 1.500000 0.177668
2024-11-15 1.300000 0.174216
2024-08-15 1.300000 0.139548
2024-05-15 1.300000 0.165180
2024-02-14 1.300000 0.171660
2023-11-14 1.130000 0.184997
2023-08-14 1.130000 0.210037
2023-05-12 1.130000 0.260111
2023-02-14 1.130000 0.325124
2022-11-14 0.980000 0.275235
2022-08-12 0.980000 0.318099
2022-05-13 0.980000 0.336042
2022-02-14 0.980000 0.417572
2021-11-12 0.850000 0.327364
2021-08-12 0.850000 0.322617
2021-05-13 0.850000 0.436032
2021-02-11 0.850000 0.419587
2020-11-12 0.740000 0.524711
2020-08-13 0.740000 0.491825
2020-05-14 0.740000 0.467231
2020-02-13 0.740000 0.521862
2019-11-14 0.645000 0.579047
2019-08-14 0.645000 0.584822
2019-05-16 0.645000 0.552557
2019-02-14 0.645000 0.534161
2018-11-14 0.563000 0.512704
2018-08-14 0.563000 0.549590
2018-05-16 0.563000 0.693521
2018-02-14 0.563000 0.730884
2017-11-14 0.520000 0.630379
2017-08-11 0.520000 0.640789
2017-05-11 0.520000 0.648217
2017-02-13 0.520000 0.668638
2016-11-10 0.510000 0.651008
2016-08-11 0.510000 0.633069
2016-05-11 0.510000 0.668327
2016-02-10 0.510000 0.697961
2015-11-10 0.500000 0.624532
2015-08-12 0.500000 0.599664
2015-05-14 0.500000 0.684369
2015-02-11 0.500000 0.714796
2014-11-12 0.490000 0.727003
2014-08-13 0.490000 0.808714
2014-05-13 0.490000 0.816123
2014-02-12 0.490000 0.918980
2013-11-13 0.490000 0.969337
2013-08-13 0.490000 0.891558
2013-05-14 0.490000 0.877036
2013-02-13 0.490000 0.916916
2012-11-13 0.490000 1.039457
2012-08-13 0.490000 1.144592
2012-05-11 0.490000 1.187591
2012-02-13 0.490000 1.261261
2011-11-10 0.490000 1.316143
2011-08-11 0.490000 1.388102
2011-05-11 0.490000 1.280042
2011-02-11 0.490000 1.419467
2010-11-10 0.490000 1.400400
2010-08-11 0.490000 1.334786
2010-05-12 0.490000 1.408856
2010-02-10 0.490000 1.434007
2009-11-10 0.490000 1.390071
2009-08-12 0.490000 1.487553
2009-05-13 0.490000 1.394026
2009-02-11 0.490000 1.334423
2008-11-12 0.470000 1.469209
2008-08-13 0.470000 0.971476
2008-05-13 0.470000 0.988433
2008-02-13 0.470000 0.933651
2007-11-13 0.425000 0.807371
2007-08-13 0.425000 0.746531
2007-05-11 0.425000 0.727366
2007-02-13 0.425000 0.782977
2006-11-13 0.400000 0.739919
2006-08-11 0.400000 0.735835
2006-05-11 0.400000 0.782473
2006-02-13 0.400000 0.722674
2005-11-10 0.380000 0.739300
2005-08-11 0.380000 0.708427
2005-05-11 0.380000 0.646809
2005-02-11 0.380000 0.684685
2004-11-10 0.355000 0.638260
2004-08-11 0.355000 0.567093
2004-05-12 0.355000 0.481617
2004-02-11 0.355000 0.475234
2003-11-12 0.335000 0.506119
2003-08-13 0.335000 0.538585
2003-05-13 0.335000 0.525078
2003-02-12 0.335000 0.568857
2002-11-13 0.310000 0.514181
2002-08-13 0.310000 0.553571
2002-05-13 0.310000 0.480025
2002-02-13 0.310000 0.407252
2001-11-13 0.280000 0.354565
2001-08-13 0.280000 0.356870
2001-05-11 0.280000 0.333731
2001-02-13 0.280000 0.350044
2000-11-13 0.260000 0.301887
2000-08-11 0.260000 0.337662
2000-05-11 0.260000 0.347245
2000-02-11 0.260000 0.421907
1999-11-10 0.230000 0.302881
1999-08-11 0.230000 0.373984
1999-05-12 0.230000 0.300899
1999-02-10 0.230000 0.263233
1998-11-10 0.200000 0.233577
1998-08-12 0.200000 0.291439
1998-05-13 0.200000 0.291439
1998-02-11 0.200000 0.302457
1997-11-12 0.200000 0.316832
1997-08-13 0.180000 0.344498
1997-05-13 0.180000 0.387618
1997-02-12 0.180000 0.397790
1996-11-13 0.171000 0.452231
1996-08-13 0.171000 0.579661
1996-05-13 0.171000 0.612081
1996-02-13 0.171000 0.533333
1995-11-13 0.171250 0.710765
1995-08-11 0.161250 0.850082
1995-05-09 0.161250 0.880546
1995-02-09 0.161250 0.982857
1994-11-08 0.156250 0.990099
1994-08-09 0.156250 1.282051
1994-05-09 0.156250 1.176471
1994-02-09 0.156250 1.082251
1993-11-08 0.151250 1.085202
1993-08-09 0.151250 1.363380
1993-05-10 0.151250 1.192118
1993-02-09 0.151250 1.112644
1992-11-06 0.137500 0.896130
1992-08-10 0.137500 0.788530
1992-05-11 0.137500 0.816327
1992-02-10 0.137500 0.694006
1991-11-08 0.125000 0.656814
1991-08-09 0.125000 0.629921
1991-05-09 0.125000 0.649351
1991-02-07 0.125000 0.676819
1990-11-08 0.102500 0.598540
1990-08-09 0.102500 0.525641
1990-05-09 0.102500 0.594203
1990-02-09 0.102500 0.653386
1989-11-09 0.084250 0.526563
1989-08-09 0.084250 0.549084
1989-05-09 0.084250 0.640380
1989-02-09 0.084375 0.711462
1988-11-08 0.071875 0.659971
1988-08-09 0.071875 0.689655
1988-05-09 0.071875 0.744337
1988-02-09 0.071875 0.787671
1987-11-06 0.062500 0.663350
1987-08-10 0.062500 0.505051
1987-05-11 0.062500 0.577201
1987-02-09 0.062500 0.588235
1986-11-07 0.056250 0.603015
1986-08-11 0.056250 0.592105
1986-05-09 0.056250 0.637168
1986-02-10 0.056250 0.805369
1985-11-08 0.050000 0.840999
1985-08-09 0.050000 0.963855
1985-05-09 0.050000 1.015873
1985-02-08 0.050000 1.097770
1984-11-08 0.050000 1.272366
1984-08-09 0.045313 1.241984
1984-05-09 0.045313 1.164671
1984-02-08 0.045313 1.181276
1983-11-07 0.045313 1.074086
1983-08-09 0.045313 1.183687
1983-05-09 0.040625 1.009709
1983-02-09 0.040625 1.083333
1982-11-05 0.040625 1.074380
1982-08-09 0.040625 1.390374
1982-05-10 0.040625 1.087866
1982-02-08 0.040625 1.142857
1981-11-06 0.035938 1.064830
1981-08-10 0.035938 1.111127
1981-05-11 0.035938 0.927432
1981-02-05 0.035938 0.936876
1980-11-07 0.035938 1.022236
1980-08-11 0.035938 1.002192
1980-05-12 0.032813 1.063307
1980-02-08 0.032813 0.976759
1979-11-02 0.032813 0.907141
1979-08-06 0.032813 0.933348
1979-05-07 0.028125 0.880195
1979-02-05 0.028125 0.944882
1978-11-03 0.028125 0.983607
1978-08-07 0.025000 0.774818
1978-05-08 0.025000 0.903955
1978-02-06 0.025000 1.012658
1977-11-03 0.022188 1.000023
1977-08-08 0.022188 1.010699
1977-05-09 0.022188 0.966008
1977-02-04 0.022188 0.832863
1976-11-05 0.020313 0.656582
1976-08-09 0.020313 0.608914
1976-05-10 0.018750 0.574163
1976-02-06 0.018750 0.545455
1975-11-07 0.017188 0.509274
1975-08-11 0.017188 0.416679
1975-05-12 0.017188 0.372261
1975-02-07 0.017188 0.402205
1974-11-08 0.015625 0.343053
1974-08-12 0.015625 0.378788
1974-05-13 0.014688 0.312303
1974-02-08 0.014688 0.357427
1973-11-12 0.012938 0.249407
1973-08-13 0.012938 0.249783
1973-05-14 0.011813 0.229101
1973-02-09 0.011813 0.239630
1972-11-13 0.011375 0.240264
1972-08-07 0.011375 0.242667
Additional Data
dividendRate 6.92
dividendYield 0.58
exDividendDate 2026-08-14
trailingAnnualDividendRate 6.23
trailingAnnualDividendYield 0.005241549
lastDividendValue 1.73
lastDividendDate 2026-05-15
dividendDate 2026-09-10

Info Dump

Attribute Value
52 Week Change 0.4869517
Address1 Lilly Corporate Center
All Time High 1,249.45
All Time Low 2.039063
Ask 1,194.0
Ask Size 80
Audit Risk 8
Average Analyst Rating 1.8 - Buy
Average Daily Volume10 Day 3,314,010
Average Daily Volume3 Month 3,299,183
Average Volume 3,299,183
Average Volume10Days 3,314,010
Beta 0.506
Bid 1,180.62
Bid Size 120
Board Risk 5
Book Value 34.917
City Indianapolis
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 5
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1,181.87
Current Ratio 1.497
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 1,196.25
Day Low 1,166.01
Debt To Equity 139.015
Dividend Date 1,788,998,400
Dividend Rate 6.92
Dividend Yield 0.58
Earnings Call Timestamp End 1,785,938,400
Earnings Call Timestamp Start 1,785,938,400
Earnings Growth 1.699
Earnings Quarterly Growth 1.681
Earnings Timestamp 1,785,933,000
Earnings Timestamp End 1,785,933,000
Earnings Timestamp Start 1,785,933,000
Ebitda 36,215,001,088
Ebitda Margins 0.50125
Enterprise To Ebitda 30.154
Enterprise To Revenue 15.115
Enterprise Value 1,092,010,442,752
Eps Current Year 36.07107
Eps Forward 44.98306
Eps Trailing Twelve Months 28.17
Esg Populated 0
Ex Dividend Date 1,786,665,600
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1,086.7544
Fifty Day Average Change 95.1156
Fifty Day Average Change Percent 0.087522626
Fifty Two Week Change Percent 48.69517
Fifty Two Week High 1,249.45
Fifty Two Week High Change -67.579956
Fifty Two Week High Change Percent -0.054087766
Fifty Two Week Low 623.78
Fifty Two Week Low Change 558.08997
Fifty Two Week Low Change Percent 0.89469033
Fifty Two Week Range 623.78 - 1249.45
Financial Currency USD
First Trade Date Milliseconds 76,253,400,000
Five Year Avg Dividend Yield 0.89
Float Shares 889,324,787
Forward Eps 44.98306
Forward P E 26.273668
Free Cashflow 9,156,599,808
Full Exchange Name NYSE
Full Time Employees 50,000
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.82832
Gross Profits 59,845,001,216
Has Pre Post Market Data 1
Held Percent Insiders 0.00155
Held Percent Institutions 0.85236
Implied Shares Outstanding 891,741,406
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Ir Website http://investor.lilly.com/
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,778,803,200
Last Dividend Value 1.73
Last Fiscal Year End 1,767,139,200
Last Split Date 876,960,000
Last Split Factor 2:1
Long Business Summary Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Long Name Eli Lilly and Company
Market us_market
Market Cap 1,053,922,361,344
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_285467
Most Recent Quarter 1,774,915,200
Net Income To Common 25,276,999,680
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,059,906,000,343
Number Of Analyst Opinions 28
Open 1,180.11
Operating Cashflow 20,480,000,000
Operating Margins 0.49386
Overall Risk 8
Payout Ratio 0.22129999
Peg Ratio 1.54
Phone 317 276 2000
Post Market Change 0.072753906
Post Market Change Percent 0.00615583
Post Market Price 1,181.9427
Post Market Time 1,783,987,165
Previous Close 1,188.58
Price Eps Current Year 32.765038
Price Hint 2
Price To Book 33.84798
Price To Sales Trailing12 Months 14.587362
Profit Margins 0.34986
Quick Ratio 0.721
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.76667
Region US
Regular Market Change -6.70996
Regular Market Change Percent -0.564536
Regular Market Day High 1,196.25
Regular Market Day Low 1,166.01
Regular Market Day Range 1,166.01 - 1196.25
Regular Market Open 1,180.11
Regular Market Previous Close 1,188.58
Regular Market Price 1,181.87
Regular Market Time 1,783,972,984
Regular Market Volume 1,525,845
Return On Assets 0.20739001
Return On Equity 1.07459
Revenue Growth 0.555
Revenue Per Share 80.613
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 9
Shares Outstanding 891,741,406
Shares Percent Shares Out 0.0105
Shares Short 9,353,153
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 9,795,475
Short Name Eli Lilly and Company
Short Percent Of Float 0.0105
Short Ratio 2.74
Source Interval 15
State IN
Symbol LLY
Target High Price 1,500.0
Target Low Price 850.0
Target Mean Price 1,243.4286
Target Median Price 1,291.5
Total Cash 5,281,999,872
Total Cash Per Share 5.923
Total Debt 43,370,000,384
Total Revenue 72,248,999,936
Tradeable 0
Trailing Annual Dividend Rate 6.23
Trailing Annual Dividend Yield 0.005241549
Trailing Eps 28.17
Trailing P E 41.954918
Trailing Peg Ratio 1.5372
Triggerable 1
Two Hundred Day Average 996.3276
Two Hundred Day Average Change 185.54242
Two Hundred Day Average Change Percent 0.18622632
Type Disp Equity
Volume 1,525,845
Website https://www.lilly.com
Zip 46,285